CGRP-receptor antagonism in migraine treatment (Q34600998)

3 August 2017

title

CGRP-receptor antagonism in migraine treatment. (English)

1 reference

3 August 2017

1 reference

Lars Edvinsson

1

1 reference

3 August 2017

language of work or name

English

0 references

publication date

25 November 2008

1 reference

3 August 2017

1 reference

3 August 2017

volume

372

1 reference

3 August 2017

issue

9656

1 reference

3 August 2017

page(s)

2089-2090

1 reference

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961710-9

7 January 2021

Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961710-9

7 January 2021

Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961710-9

7 January 2021

Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961710-9

7 January 2021

Cerebrovascular responses to capsaicin in vitro and in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961710-9

7 January 2021

Calcitonin gene-related peptide: functional role in cerebrovascular regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961710-9

7 January 2021

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961710-9

7 January 2021

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961710-9

7 January 2021

Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961710-9

7 January 2021

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961710-9

7 January 2021

Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961710-9

7 January 2021

Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961710-9

7 January 2021

10.1016/S0140-6736(08)61710-9

Identifiers

DOI

1 reference

3 August 2017

1 reference